𝔖 Bobbio Scriptorium
✦   LIBER   ✦

787 GROWTH HORMONE-RELEASING HORMONE ANTAGONIST INHIBITS GROWTH OF PC-3 HUMAN PROSTATE CANCER BY INACTIVATION OF ERK AND AKT

✍ Scribed by Rick, Ferenc; Seitz, Stephan; Szalontay, Luca; Block, Norman; Zarandi, Marta; Hohla, Florian; Buchholz, Stefan; Schally, Andrew

Book ID
118485561
Publisher
Lippincott Williams and Wilkins
Year
2012
Tongue
English
Weight
284 KB
Volume
187
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of PC-3 human prostate cancer
Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity
✍ Artur Plonowski; Jozsef L. Varga; Andrew V. Schally; Magdalena Krupa; Kate Groot πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 202 KB

## Abstract Vasoactive intestinal peptide (VIP) stimulates the proliferation and invasiveness of malignant prostatic cells. Receptors for VIP and the closely related growth hormone‐releasing hormone (GH‐RH) show considerable homology and are found in prostatic and other carcinomas. Among various an

Novel antagonists of growth hormone-rele
Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers
✍ Anna Klukovits; Andrew V. Schally; Luca Szalontay; Irving Vidaurre; Andrea Papad πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 877 KB

## Abstract ## BACKGROUND: Antagonists of growth hormone‐releasing hormone (GHRH) inhibit the proliferation of various human cancer cell lines and experimental tumors by mechanisms that include direct action on GHRH receptors in cancer cells. ## METHODS: In this study, the effects of newly synth

Targeted cytotoxic analog of luteinizing
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice
✍ KoppοΏ½n, Miklos; Nagy, Attila; Schally, Andrew V.; Plonowski, Artur; Halmos, GοΏ½bo πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 2 views

## Background: Receptors for luteinizing hormone-releasing hormone (lh-rh) found in prostate cancers might be used for targeting of chemotherapeutic agents. doxorubicin derivative 2-pyrrolinodoxorubicin (an-201) can be linked to carrier analog [d-lys6]lh-rh to form the targeted cytotoxic analog of

Luteinizing hormone-releasing hormone an
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
✍ Jungwirth, Andreas; Galvan, Georg; Pinski, Jacek; Halmos, Gabor; Szepeshazi, Kar πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 2 views

## Background: Hormones like bombesin (bn)/gastrin-releasing peptide (grp) and luteinizing hormone-releasing hormone (lh-rh) and growth factors such as epidermal growth factor (egf) might be involved in the relapse of prostate cancer under androgen ablation therapy. interference with receptors for